$62.37
-1.99-3.09%
Last update: Nov 6, 7:46 PM
GeneDx Holdings Corp
WGSNASDAQ
The average analyst price target for GeneDx Holdings is $88.40, 40.9% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $63 to $118. The latest change came on Oct 1, 2026, when Guggenheim raised its price target on GeneDx Holdings from $74 to $83 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
